Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer

Схожие документы

• Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
  по: Willett, Christopher G., et al.
  Опубликовано: (2009)
• Preoperative Radiation Therapy with Concurrent Capecitabine, Bevacizumab and Erlotinib for Rectal Cancer: A Phase I Trial
  по: Das, Prajnan, et al.
  Опубликовано: (2013)
• Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer
  по: Klautke, G, et al.
  Опубликовано: (2005)
• The impact of 5-fluorouracil and intraoperative electron beam radiation therapy on the outcome of patients with locally advanced primary rectal and rectosigmoid cancer.
  по: Nakfoor, B M, et al.
  Опубликовано: (1998)
• Phase 1 Study of Neoadjuvant Short-Course Radiation Therapy Concurrent With Infusional 5-Fluorouracil for the Treatment of Locally Advanced Rectal Cancer
  по: Fields, Emma C., et al.
  Опубликовано: (2019)